AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 277 filers reported holding AVANOS MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $456,000 | -0.4% | 13,556 | +2.1% | 0.00% | – |
| Q4 2021 | $458,000 | -13.3% | 13,273 | -20.2% | 0.00% | – |
| Q3 2021 | $528,000 | -17.1% | 16,629 | -3.3% | 0.00% | – |
| Q2 2021 | $637,000 | +186.9% | 17,189 | +232.3% | 0.00% | – |
| Q1 2021 | $222,000 | -58.6% | 5,173 | -53.8% | 0.00% | – |
| Q4 2020 | $536,000 | +144.7% | 11,189 | +86.6% | 0.00% | – |
| Q3 2020 | $219,000 | +1.4% | 5,995 | -20.5% | 0.00% | – |
| Q2 2020 | $216,000 | +307.5% | 7,545 | +247.1% | 0.00% | – |
| Q1 2020 | $53,000 | -87.1% | 2,174 | -82.2% | 0.00% | – |
| Q4 2019 | $410,000 | +61.4% | 12,180 | +79.1% | 0.00% | – |
| Q3 2019 | $254,000 | -14.5% | 6,802 | +0.0% | 0.00% | – |
| Q2 2019 | $297,000 | +135.7% | 6,801 | +131.1% | 0.00% | – |
| Q1 2019 | $126,000 | -23.2% | 2,943 | -19.3% | 0.00% | – |
| Q4 2018 | $164,000 | -16.8% | 3,648 | +26.7% | 0.00% | – |
| Q3 2018 | $197,000 | – | 2,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |